Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
PHARMBIOTECH OY
OY
Dissolved
Y-tunnus 2513575-3
Asentajantie 8, 06150
Porvoo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2012 · 13 years old
0 employees
www.biopharmos.group
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
PHARMBIOTECH OY
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
0M
2024
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
0M
0%
2024
Income statement
EUR thousands
Item
2019
2020
2021
2022
2024
Revenue
−29
0
2
0
0
Staff expenses
—
−2
−1
—
−0
EBITDA
−58
−19
−4
−0
185
Depreciation & amort.
−0
—
−23
−22
−185
EBIT
−58
−19
−27
−22
—
Net financials
−1
—
−0
—
0
Profit before tax
−59
−19
−27
−22
−185
Tax
2
−0
−0
−0
−0
Net profit
−60
−19
−27
−22
−185
Balance sheet
EUR thousands
Item
2019
2020
2021
2022
2024
Total assets
306
294
266
243
36
Equity
305
287
260
238
30
Long-term debt
—
—
—
—
0
Short-term debt
1
7
6
5
6
Total debt
1
7
6
5
6
Financial ratios
5-year trend
EBITDA-margin
18491100.0%
This company
15.8%
Market median
+117032178% vs market
2019
2024
Soliditetsgrad
82.9%
This company
38.2%
Market median
+117% vs market
2019
2024
Egenkapitalforrentning
-625.5%
This company
18.4%
Market median
-3499% vs market
2019
2024
Nettoresultatgrad
-18491100.0%
This company
8.1%
Market median
-228285285% vs market
2019
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2019
2024
Gæld/egenkapital
0.21×
This company
0.62×
Market median
+66% vs market
2019
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
More on PHARMBIOTECH OY
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network